Condensed Consolidated Balance Sheets - USD ($) $ in Millions		Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash		$ 122	$ 17
Trade receivables		155	277
Inventories		61	67
Other current assets, net		82	130
Total current assets		420	491
PROPERTY, PLANT AND EQUIPMENT		22,915	22,889
Accumulated depreciation, depletion and amortization		(18,555)	(16,537)
Total property, plant and equipment, net		4,360	6,352
OTHER ASSETS		76	115
TOTAL ASSETS		4,856	6,958
CURRENT LIABILITIES
Current portion of long-term debt		0	100
Debtor-in-possession financing		733	0
Accounts payable		221	296
Accrued liabilities		240	313
Total current liabilities		1,194	709
LONG-TERM DEBT		0	4,877
DEFERRED GAIN AND ISSUANCE COSTS, NET		0	146
OTHER LONG-TERM LIABILITIES		727	720
LIABILITIES SUBJECT TO COMPROMISE		4,516	0
MEZZANINE EQUITY
Redeemable noncontrolling interests		692	802
EQUITY
Preferred stock (20 million shares authorized at $0.01 par value) no shares outstanding at September 30, 2020 and December 31, 2019		0	0
Common stock (200 million shares authorized at $0.01 par value) outstanding shares (September 30, 2020 - 49,498,227 and December 31, 2019 - 49,175,843)		0	0
Additional paid-in capital		5,148	5,004
Accumulated deficit		(7,466)	(5,370)
Accumulated other comprehensive loss		(23)	(23)
Total equity attributable to common stock		(2,341)	(389)
Equity attributable to noncontrolling interests		68	93
Total equity	[1]	(2,273)	(296)
TOTAL LIABILITIES AND EQUITY		$ 4,856	$ 6,958

[1] The above tables exclude amounts related to redeemable noncontrolling interests reported in mezzanine equity. See Note 7 Joint Ventures for more information about our noncontrolling interests and a settlement agreement entered into with one of our noncontrolling interest holders in the third quarter of 2020 where the modification of terms was treated as a return from noncontrolling interest holders.